Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine as the Main Analgesic Agent During Analgesia-based Sedation for Elective Colonoscopy- a Randomised, Double-blind, Control Study

NCT05421962 is registered in ClinicalTrials.gov with Cantonal Hospital Zenica as lead sponsor.

NCT NCT05421962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine as the Main Analgesic Agent During Analgesia-based Sedation for Elective Colonoscopy- a Randomised, Double-blind, Control Study
Lead sponsor
Cantonal Hospital Zenica
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2020
Completion date
December 15, 2021
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pain, side effect